Abstract:Objective:The aim of this study was to develop and validate an ultra-performance liquid chromatographic (UPLC) method with photodiode array detector for the measurement of vancomycin in human serum samples for therapeutic drug monitoring or other applications.Methods:The method included the extraction of vancomycin in serum by deproteinization with acetonitrile. The analyses were carried out using an ACQUITY UPLC BEH C-18 column (2.1 x 50 mm, 1.7 m) using acetonitrile and 0.005 M KH2PO4 buffer (pH 2.5) as the mobile phase at a flow rate of 0.3 mL/min, with photodiode array detection at 230 nm. The method was validated for extraction recovery, inter- and intraday precision (relative standard deviation, RSD%), and accuracy and stability of vancomycin in serum. Both the established UPLC method and fluorescence polarization immunoassay (FPIA) were used to measure the prepared quality control (QC) samples (1.0, 7.0, 35.0, 75.0 mg/L) to validate the accuracy of UPLC. Furthermore, both methods were subsequently used to assay the vancomycin concentration in 172 clinical serum samples collected from patients receiving vancomycin in the hospitals localized in Shanghai (China) and 32 control samples from United Kingdom National External Quality Assessment Service (UK NEQAS).Results:The retention time of vancomycin was 2.6 minutes. The calibration curve for UPLC was linear over the range 1.0-100.0 mg/L (R-2 > 0.999). The method was fully validated in terms of recovery, selectivity, accuracy, precision, and various conditions. The absolute difference% and RSD% of the prepared QC samples assayed by UPLC were all better than the results by FPIA. A paired t test of the results of the prepared QC samples indicated that the results of all the QC samples had significant difference (P < 0.05), except for the 7.0 mg/L QC samples, which suggested that UPLC was more accurate for the samples containing low or high concentration of vancomycin. A correlation with the Deming model provided a good linear relation between the results of the 2 methods applied to 172 samples, with equation of UPLC = 0.99 x FPIA - 0.19 (R-2= 0.923), and the agreement of the 2 methods was illustrated using Bland-Altman plot with a mean difference (UPLC - FPIA) of -0.428 mg/L and 95% confidence interval of -8.33 to 7.47 mg/L, respectively. A Student t test comparing results obtained by the UPLC method and group mean results of control samples from UK NEQAS were not significant (P = 0.057).Conclusions:A short analysis time, small amount of serum needed, high specificity, and accuracy make the UPLC method developed in this study appropriate and practical for vancomycin therapeutic drug monitoring and could be applied to other nonserum applications or where requiring superior validation parameters such as for pharmacokinetic/pharmacodynamic studies.

An optimized HPLC method for determination of the drug loading and release of norvancomycin-bonded Dacron prostheses in vitro

Preparation of Norvancomycin-Bonded Dacron Prostheses

Measurement of in vitro antibacterial activity of norvancomycin-bonded Dacron prostheses

Determination of Vancomycin and Norvancomycin in human serum by HPLC

Establishment of norvancomycin fluorescence polarization immunoassay for therapeutic drug monitoring

Sustainable release of vancomycin, gentamicin and lidocaine from novel electrospun sandwich-structured PLGA/collagen nanofibrous membranes

Simultaneous Separation and Determination of Vancomycin and Its Crystalline Degradation Products in Human Serum by Ultra High Performance Liquid Chromatography Tandem Mass Spectrometry Method and Its Application in Therapeutic Drug Monitoring

Effect of Ultrasound on Drug Release of Vancomycin-Loaded Acrylic Bone Cement

Development and Validation of A New Ultra-Performance Liquid Chromatographic Method for Vancomycin Assay in Serum and Its Application to Therapeutic Drug Monitoring

Determination of Glucosamine and Its Derivatives Released from Photocrosslinked Gelatin Hydrogels Using HPLC

Preparation and characteristics of a novel biodegradable antibiotics-eluting nanofiber-loaded bone scaffold

Establishment of Chromatographic Methods for the Determination of Vancomycin in Human Serum

Surface molecularly imprinted solid-phase extraction for the determination of vancomycin in plasma samples using HPLC-MS/MS

Preparation and in Vitro Study of Hydrochloric Norvancomycin Encapsulated Poly (D,l-Lactide-co-glycolide, PLGA) Microspheres for Potential Use in Osteomyelitis

An Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method to Quantify Vancomycin in Human Serum by Minimizing the Degradation Product and Matrix Interference

Enhancement of Intermittent, Low-Frequency and Elevated-Intensity Insonation on Local Pharmacokinetics of Vancomycin-Loaded Bone Cement in Vitro

Development and Validation of Liquid Chromatographic Method for Fast Determination of Lincomycin, Polymyxin and Vancomycin in Preservation Solution for Transplants

In Vitro and in Vivo Evaluation of Vancomycin-Loaded PMMA Cement in Combination with Ultrasound and Microbubbles-Mediated Ultrasound

In vitro drug release and antibacterial activity evaluation of silk fibroin coated vancomycin hydrochloride loaded poly (lactic-co-glycolic acid) (PLGA) sustained release microspheres

Study on pharmacokinetics and tissue distribution of norvancomycin in rats by CE with electrochemical detection.

Rapid Monitoring of Vancomycin Concentration in Serum Using Europium (III) Chelate Nanoparticle-Based Lateral Flow Immunoassay